Literature DB >> 32266653

Hyaluronan in the Tumor Microenvironment.

Fiorella Mercedes Spinelli1, Daiana Lujan Vitale1, Ina Sevic1, Laura Alaniz2.   

Abstract

The extracellular matrix is part of the microenvironment and its functions are associated with the physical and chemical properties of the tissue. Among the extracellular components, the glycosaminoglycan hyaluronan is a key component, defining both the physical and biochemical characteristics of the healthy matrices. The hyaluronan metabolism is strictly regulated in physiological conditions, but in the tumoral tissues, its expression, size and binding proteins interaction are dysregulated. Hyaluronan from the tumor microenvironment promotes tumor cell proliferation, invasion, immune evasion, stemness alterations as well as drug resistance. This chapter describes data regarding novel concepts of hyaluronan functions in the tumor. Additionally, we discuss potential clinical applications of targeting HA metabolism in cancer therapy.

Entities:  

Keywords:  CD44; Cancer Stem Cells; Cancer therapy; DNA damage; Drug Resistance; Extracellular Matrix; Hyaluronan; Hyaluronan Synthases; Hyaluronan metabolism; Hyaluronidases; Immune response; Stemness; Tumor microenvironment; Tumor-Associated Macrophages; UGDH

Mesh:

Substances:

Year:  2020        PMID: 32266653     DOI: 10.1007/978-3-030-40146-7_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Oral hymecromone decreases hyaluronan in human study participants.

Authors:  Joelle I Rosser; Nadine Nagy; Riya Goel; Gernot Kaber; Sally Demirdjian; Jamie Saxena; Jennifer B Bollyky; Adam R Frymoyer; Ana E Pacheco-Navarro; Elizabeth B Burgener; Jayakumar Rajadas; Zhe Wang; Olga Arbach; Colleen E Dunn; Anissa Kalinowski; Carlos E Milla; Paul L Bollyky
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

2.  Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Deyu Zhang; Jiahong Liu; Tian Xie; Qiwei Jiang; Lihua Ding; Jianhua Zhu; Qinong Ye
Journal:  Int J Biol Sci       Date:  2020-08-27       Impact factor: 6.580

3.  Breast Cancer Cell Cultures on Electrospun Poly(ε-Caprolactone) as a Potential Tool for Preclinical Studies on Anticancer Treatments.

Authors:  Bianca Bazzolo; Elisabetta Sieni; Annj Zamuner; Martina Roso; Teresa Russo; Antonio Gloria; Monica Dettin; Maria Teresa Conconi
Journal:  Bioengineering (Basel)       Date:  2020-12-22

Review 4.  Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?

Authors:  Claire Deligne; Kim S Midwood
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

Review 5.  Hyaluronan Functions in Wound Repair That Are Captured to Fuel Breast Cancer Progression.

Authors:  Cornelia Tolg; Britney Jodi-Ann Messam; James Benjamin McCarthy; Andrew Cook Nelson; Eva Ann Turley
Journal:  Biomolecules       Date:  2021-10-20

6.  Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.

Authors:  Sofía Valla; Nourhan Hassan; Daiana Luján Vitale; Daniela Madanes; Fiorella Mercedes Spinelli; Felipe C O B Teixeira; Burkhard Greve; Nancy Adriana Espinoza-Sánchez; Carolina Cristina; Laura Alaniz; Martin Götte
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

Review 7.  Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions.

Authors:  Saleh Ramezani; Arianna Parkhideh; Pratip K Bhattacharya; Mary C Farach-Carson; Daniel A Harrington
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

8.  Human Hyaluronidase PH20 Potentiates the Antitumor Activities of Mesothelin-Specific CAR-T Cells Against Gastric Cancer.

Authors:  Ruocong Zhao; Yuanbin Cui; Yongfang Zheng; Shanglin Li; Jiang Lv; Qiting Wu; Youguo Long; Suna Wang; Yao Yao; Wei Wei; Jie Yang; Bin-Chao Wang; Zhenfeng Zhang; Hui Zeng; Yangqiu Li; Peng Li
Journal:  Front Immunol       Date:  2021-07-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.